DK0839050T3 - Fremgangsmåde til at forstærke celleformidlede immunreaktioner - Google Patents

Fremgangsmåde til at forstærke celleformidlede immunreaktioner

Info

Publication number
DK0839050T3
DK0839050T3 DK93921698T DK93921698T DK0839050T3 DK 0839050 T3 DK0839050 T3 DK 0839050T3 DK 93921698 T DK93921698 T DK 93921698T DK 93921698 T DK93921698 T DK 93921698T DK 0839050 T3 DK0839050 T3 DK 0839050T3
Authority
DK
Denmark
Prior art keywords
mediated immune
immune responses
enhancing cell
enhancing
immunogen
Prior art date
Application number
DK93921698T
Other languages
Danish (da)
English (en)
Inventor
Balbir S Bhogal
Krishnaswamy I Dayalu
Jay D Gerber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0839050T3 publication Critical patent/DK0839050T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK93921698T 1992-09-28 1993-09-21 Fremgangsmåde til at forstærke celleformidlede immunreaktioner DK0839050T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95224892A 1992-09-28 1992-09-28
PCT/US1993/008900 WO1994007531A1 (en) 1992-09-28 1993-09-21 Method of enhancing cell mediated immune responses

Publications (1)

Publication Number Publication Date
DK0839050T3 true DK0839050T3 (da) 2004-10-25

Family

ID=25492700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93921698T DK0839050T3 (da) 1992-09-28 1993-09-21 Fremgangsmåde til at forstærke celleformidlede immunreaktioner

Country Status (11)

Country Link
EP (1) EP0839050B1 (de)
JP (1) JPH08502253A (de)
AT (1) ATE273022T1 (de)
AU (1) AU687750B2 (de)
CA (1) CA2145760A1 (de)
DE (1) DE69333588T2 (de)
DK (1) DK0839050T3 (de)
ES (1) ES2225825T3 (de)
MX (1) MX9306016A (de)
PT (1) PT839050E (de)
WO (1) WO1994007531A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060284B1 (en) 1999-08-03 2006-06-13 The Ohio State University Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
EP2027873B8 (de) 2001-07-02 2015-11-11 Zoetis Services LLC Vakzination in einer Dosis mit Mycoplasma Hyopneumoniae
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
EP1912680B1 (de) 2005-06-15 2014-11-26 The Ohio State University Research Foundation Her-2-peptide
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
EP2200643B1 (de) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. Ein lawsonia intracellularis lebendimpfstoff verabreicht in kombination mit einem antibiotikum zur behandlung von lawsonia intracellularis infektionen in schweine
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
WO2011141443A1 (en) 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
ES2112274T5 (es) * 1990-05-29 2006-03-01 Wyeth Holdings Corporation Vacuna contra la pneumonia en cerdos y metodo para la preparacion de la misma.
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof

Also Published As

Publication number Publication date
JPH08502253A (ja) 1996-03-12
DE69333588T2 (de) 2005-08-04
WO1994007531A1 (en) 1994-04-14
PT839050E (pt) 2004-11-30
AU4931293A (en) 1994-04-26
EP0839050A1 (de) 1998-05-06
CA2145760A1 (en) 1994-04-14
EP0839050A4 (de) 1998-05-06
ES2225825T3 (es) 2005-03-16
EP0839050B1 (de) 2004-08-11
DE69333588D1 (de) 2004-09-16
MX9306016A (es) 1995-01-31
AU687750B2 (en) 1998-03-05
ATE273022T1 (de) 2004-08-15

Similar Documents

Publication Publication Date Title
ATE95425T1 (de) Impfstofformulierung.
SG46445A1 (en) Vaccines against cancer and infectious diseases
DK157087A (da) Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
FI943171A0 (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
WO1995020660A3 (en) Immunization by inoculation of dna transcription unit
BR9106748A (pt) Vacina de hyopneumomiae micoplasma inativado e metodo de seu uso
NO20011586D0 (no) Nye metoder for terapeutisk vaksinasjon
NO950739L (no) Vaksiner mot gruppe C Neisseria Meningtidis
DK0839050T3 (da) Fremgangsmåde til at forstærke celleformidlede immunreaktioner
NO954318D0 (no) Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener
FI875015A0 (fi) Vaccin mot juverinflammation.
DE68917138D1 (de) Toleranzinduktion gegenüber einem fremdantigen.
EP0636030A4 (de) Impfstoff gegen das bacterientoxoid aus -i (pasteurellia haemolytica).
Toma et al. Vaccination of dogs against rabies. Comparison of serological responses one year after intradermal or subcutaneous vaccination
Kraaijeveld et al. Delayed type hypersensitivity against semliki forest virus in mice: local transfer of delayed type hypersensitivity with thioglycollate-induced peritoneal exudate cells
Szemeredi et al. Guinea pig model experiment for testing the efficiency of leptospiral vaccine.
SE9600646D0 (sv) Vaccin
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
Zheng et al. Studies on the biological properties of a chemical vaccine prepared from antigenic fractions of Vibrio cholerae.
Dong et al. Preparation of various cholera vaccines and comparison of their immuno-effect.
YU et al. Comparision of immunogenicity of vaccine produced by different rabies the strain
NO905619L (no) Identifikasjon av humane t-lymfocyttepitoper i patogener for vaksineutvikling.
RU2000102946A (ru) Способ вакцинотерапии онкозаболеваний
SE8605145D0 (sv) Anordning for uppvermning av dynor, stolsitsar och dylikt